Fresh Rounds

Halia Therapeutics, Inc. funding

Halia Therapeutics, Inc., a biotechnology company based in Lehi, UT, filed a Form D with the SEC on August 31, 2026 and reported $3.5M raised of a $20M offering.

Amount raised$3.5M
Offering size$20M
Filed with the SECAugust 31, 2026
First saleAugust 17, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Other
LocationLehi, UT
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far9
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Utah